MIST

0.37117.06%
JN

Jeffrey Nelson

Chief Operating Officer

Mr. Jeffrey Nelson, also known as Jeff, serves as Chief Operating Officer at Milestone Pharmaceuticals Inc. since June 2020. Mr. Nelson joined Milestone Pharmaceuticals in 2018 as Vice President of Program Management and has experience in the pharmaceutical and biotech field, working primarily in project management, clinical operations, regulatory affairs, drug supply and distribution and public finance. He served as Vice President of Program Management at Mateon Therapeutics, Inc. since joining it in September 2015 until October 5, 2017. Mr. Nelson has financial and operational experience in the biopharmaceutical industry. He served as Senior Director of Clinical Operations at Axsome, Inc. From 2009 to 2014, He served as Senior Director of Business Development and Strategic Planning at Chelsea Therapeutics, Inc. From 2005 to 2009, Mr. Nelson served as Vice President of Equity Research at Ladenburg Thalmann Financial Services Inc. Previously Mr. Nelson was Manager, Products and Business Development, at the Arrow Group. He has experience in the generic pharmaceutical industry at Arrow Group and Cobalt Pharmaceuticals. He was a regulatory, manufacturing and strategic consultant for several IND and discovery stage biotech start-up companies. He covered the life sciences sector with a focus on immunology, antibody therapeutics and platform technology companies. Mr. Nelson received a B. A. in Economics from Brandeis University.

Positions